The results for liver cancer [17] and pancreatic cancer [28] were similar to those of previous studies; however, Wang et al. demonstrated that RBP4 expression was increased in ovarian cancer [29], which contradicts our present results. Here, RBP4 is linked to ovarian carcinoma.